Vivos Therapeutics, Inc. Common Stock (VVOS) is a publicly traded Healthcare sector company. As of November 17, 2026, VVOS trades at $0.08 with a market cap of $1.97M and a P/E ratio of -0.08. VVOS moved -13.67% today. Year to date, VVOS is -96.66%; over the trailing twelve months it is -96.39%. Its 52-week range spans $0.07 to $7.95. Rallies surfaces VVOS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for VVOS, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $0.08 |
| Market Cap | $1.97M |
| P/E Ratio | -0.08 |
| EPS | $-1.90 |
| Dividend Yield | 0.00% |
| 52-Week High | $7.95 |
| 52-Week Low | $0.07 |
| Volume | 4.72M |
| Avg Volume | 0 |
| Revenue (TTM) | $20.90M |
| Net Income | $-25.63M |
| Gross Margin | 61.90% |
VVOS analyst coverage data. Average price target: $0.00.